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Abstract
Pre-transplant kidney biopsy is routinely used to decide whether kidneys from marginal donors should be transplanted as single or double trans-
plantation. This is a 5-year extension of the follow-up of a previous study. In that study, graft outcomes were compared retrospectively between 
a group of 44 recipients of a single kidney graft from an extended criteria donor and a Karpinski histological score of ≤3, and another group 
of 56 recipients of a single transplant with a Karpinski histological score of 4 or 5. After 5 years of transplantation, there was no difference 
between the two groups in terms of recipient’s serum creatinine levels (1.8 ± 0.5 vs 1.9 ± 0.6 mg/dL, P = 0.5), creatinine clearance (53 ± 23 vs 49 ± 
27.0 mL/min, P = 0.6), or the rates of graft loss (41% vs 49%,P = 0.5). Therefore, the choice between single and double transplant should not be 
made only on the basis of histological score but should be done together with the evaluation of donor’s clinical parameters, especially the renal 
function. 
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Introduction
Kidney transplantation is the best treatment for end-stage 
renal disease (ESRD), since it guarantees a better quality of 
life and longer patient survival than dialysis (1). Although 
the use of extended criteria donors (ECDs) (2–4), dual kid-
ney transplantation, non-heart beating donors (5), living 
and kidney paired donation (6), and ABO-incompatible 
transplantation (7) has increased the number of transplanta-
tions performed every year, the gap between organ’s demand 
and offer is still increasing. Although in this era researchers 
are investigating the promising potential of regenerative 
nephrology (8), an important area of research is directed to 
increase the number of transplantation by optimization of 
the usage of kidneys harvested from “always more marginal 
donors” to find the border between a transplantable organ 
and an insufficient renal function.
Pre-implantation kidney biopsy is a tool to define organ 
transplantability and to distinguish whether a kidney from 
an ECD should be allocated as a single kidney transplant 
(SKT) or a double kidney transplant (DKT) (9). Until a 
few years ago, in our country, most of the transplant centers 
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Briefly, we selected from our cohort of transplanted 
patients 100 consecutive recipients of an SKT from an 
ECD with an eGFR of at least 55 mL/min at the time of 
organ retrieval. Of these, after 5 years of follow-up, we com-
pared retrospectively 44 recipients with a pre-implantation 
Karpinski histological score of ≤3 and 56 recipients who had 
a Karpinski histological score of 4 or 5.
Basal characteristics of both donors and recipients are 
compared in the original paper and reported here in Table 1 
for completeness.
We compared renal function in terms of creatinine and 
creatinine clearance using Student’s t-test for independent 
samples or the Wilcoxon’s rank-sum test, as appropriate. 




As discussed in our previous paper (13), the baseline char-
acteristics of donors and recipients were similar in the two 
groups and are reviewed in Tables 1 and 2.
allocated kidneys to either SKT or DKT if  the Karpinski 
histological score (10) was ≤3 or 4–6, respectively, accord-
ing to the protocol described by Remuzzi et al. (11, 12). It 
is a common practice nowadays to be less stringent with this 
threshold, and today most of the transplant centers choose 
an SKT even if  the Karpinski histological score is 4 or 5, but 
this choice is based more on the experience of the transplant 
center, rather than on the results of published studies.
In a previous study (13), we observed that SKT was per-
formed with the Karpinski histological score of ≤3 as well as 
the score of 4 or 5 after 3 years of follow-up, provided that 
the donor had a good renal function (estimated Glomerular 
Filtration Rate [eGFR] > 55 mL/min) at the time of organ 
harvesting. This is a 5-year follow-up extension of our pre-
vious study to see whether the non-inferior outcomes of kid-
neys with the worst pathological lesions are maintained in 
the long term.
Materials and methods
Materials and methods are described in detail in our original 
work (13).
Table 1: Donors’ characteristics.
Group A Group B P





























Hypertension (%) 31.8 50 0.10








Group A Group B
Karpinski’s histological score Score 1: 2 (4.5%)
Score 2: 13 (29.5%)
Score 3: 29 (65.9%)
Score 4: 32 (57.1%)
Score 5:24 (42.9%)
Vascular score Score 0: 4 (9.1%)
Score 1: 38 (86.4%)
Score 2: 2 (8.3%)
Score 1: 34 (60.7%)
Score 2: 22 (39.3%)
eGFR: estimated glomerular filtration rate.
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Table 2: Recipients’ characteristics and results 5 years after transplantation.
Group A Group B P














Creatinine levels (mg/dL) 1.8 ± 0.5 1.9 ± 0.6 0.5
eGFR (mL/min) 53 ± 23 49 ± 27 0.6
Age (years) 60.18 ± 6.09 60.33 ± 6.07 1.0
Males 32 (72.7%) 40 (73.2%) 1.0
DGF 25 (58.1%) 22 (39.3%) 0.063






















Biopsy proven acute rejection 8 (18.2%) 8 (14.3%) 0.598
Return to dialysis 5 (11%) 9 (17%) 0.7












Continuous variables are expressed as mean values ± standard deviation, except for HLA mismatch (expressed as median 
values and quartiles). ADPKD: autosomal dominant polycystic kidney disease; GN: glomerulonephritis; IgAN: IgA 
nephropathy; HLA: human leukocyte antigen; eGFR: estimated glomerular filtration rate; DGF: delayed graft function.
Renal function after 5 years of transplantation was not 
different between the two groups in terms of serum creati-
nine levels (1.8 ± 0.5 vs 1.9 ± 0.6 mg/dL, P = 0.5) or eGFR 
(53 ± 23 vs 49 ± 27.0 mL/min, P = 0.6).
Survival analysis
Patient survival after 5 years was 72% and 64% in groups 
A and B, respectively. The cause of  death was related to 
infectious complications in 58.3%, cardiovascular dis-
ease in 33.3%, and malignancies in 8.4% of  recipients in 
group A, while in group B, the cause of  death was related 
to infection in 61.1%, cardiovascular disease in 11.1%, and 
other causes in 27.7% of  recipients. Death-censored graft 
survival was 90.7% and 86.8% of  patients in groups A and 
B, respectively.
The Kaplan–Meier curves of death uncensored graft sur-
vival are shown in Figure 1. The log-rank analyses of both 
curves did not reveal any statistically significant difference 
in 5-year graft survival (P = 0.41) between the two groups. 
In the Cox regression, cold ischemia time and recipient’s age 
were the only covariates that had an influence on graft sur-
vival (Table 3).
Other parameters
As reported in our previous study, other parameters that we 
evaluated might have had an influence on graft survival or 
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of kidney after 5 years between patient groups with PTDB 
based on the Remuzzi score of ≤4 and different KDPI. 
The cited study concludes that organs with KDPI > 91% 
and PTDB based on the Remuzzi score = 4 are suitable for 
assignment to SKT, with guarantee of good survival despite 
the high calculated risk and high Remuzzi score. This study 
underlines that it is essential to integrate clinical data with 
biopsy data, while the exclusive use of one of the two meth-
ods is excessively restrictive.
In 2015, Wang et al. (15) published a systematic review 
of medical literature on the utility of both procurement and 
implantation biopsies for predicting post-transplant out-
comes. Between January 1, 1994 and July 1, 2014, 47 stud-
ies were published that examined the association between 
pretransplant donor biopsy findings of 50 or more donors 
(with more than half  being from deceased donors) and either 
post-transplant graft failure, delayed graft function, or graft 
function. Of 15 semiquantitative scoring systems proposed, 
none consistently predicted post-transplant outcomes across 
studies, suggesting that the role of pretransplant kidney 
biopsy may be reconsiderated.
We recognize limitations of our study: it is a retrospective 
study, analyzes the data of a single center, and takes into 
consideration a small patient population.
Another aspect to underline concerns is histology: biopsy 
analyses can be influenced by operator-dependent variability. 
The transplants selected in the study were performed within 
a 5-year period. A 5-year follow-up is enough period to pre-
dict long-term survival of transplant in the group with the 
worst histological score.
The age and glomerular filtrate of donors are statistically 
different between the two groups; paradoxically, group B 
donors have better basal characteristics. Comparing data, 
renal function were not statistically diffrentin both groups. 
The rate of acute rejection has been 18% and 14% in groups 
A and B, respectively. The rate of delayed graft function was 
comparable in both groups (56% vs 39%; P = 0.06).
Discussion
In this study, we compared retrospectively the graft outcomes 
and renal function 5 years after transplantation of SKT har-
vested from ECD withthe standard Karpisnki histological 
score (KS ≤ 3, Group A) versus SKT with a score usually 
transplanted as DKT (KS = 4 or 5, Group B). The histologi-
cal criteria to allocated kidneys from ECD donors are based 
on the Remuzzi study (12).
Our data analysis confirms the results obtained in the pre-
vious study, which compared the outcomes after 2 years of 
the transplant (13): there are no statistically significant dif-
ferences for organ survival between the two groups. A good 
kidney function can guarantee a good organ survival regard-
less of the histological score (provided ≤5). Five-year organ 
survival is similar between the two groups (P = 0.4) and it’s 
the same for patient survival (P = 0.61).
This study could underline the importance of the evalua-
tion of donor’s renal function in addition to the histological 
score. 
In literature we can find other studies on ECD that agree 
with our study. 
In 2017, Escuredo et al. (14) published a study on organ 
allocation based on the Kidney Donor Profile Index (KDPI) 
and Pretransplant Donor Biopsies (PTDB). The cited study 
analyzes the problem of allocation decision in the man-
ner opposite to ours, that is, at many centers, kidneys with 
KDPI  > 85% are discarded. They compared the survival 
Table 3: Cox regression.
HR 95% CI P
Inferior Superior
Recipient’s age 1.071 1.004 1.142 0.036
Donor’s age 0.976 0.904 1.054 0.540
Cold ischemia 1.133 1.016 1.264 0.025
Donor’s serum creatinine 3.155 0.748 13.305 0.118
Histological score 1–3 or 4–5 0.663 0.311 1.413 0.287
Kidney longitudinal dimension 1.004 0.961 1.048 0.866
Acute rejection 0.487 0.193 1.227 0.127
DGF 0.942 0.461 1.925 0.870
DGF: delayed graft function; 95% CI: 95% confidence interval.
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Figure 1: Kaplan–Meier curves for graft survival.
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